Previous close | 2.6000 |
Open | 2.6000 |
Bid | 1.4000 |
Ask | 3.2000 |
Strike | 3.50 |
Expiry date | 2024-01-19 |
Day's range | 2.6000 - 2.6000 |
Contract range | N/A |
Volume | |
Open interest | 36 |
GERMANTOWN, Md., September 14, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Gilmartin Group Emerging Growth Company Showcase, taking place virtually.
GERMANTOWN, Md., September 11, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it has entered into a $50 million loan facility with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"). The company also announced it drew down $25 million upon the transaction closing.
Senseonics (SENS) delivered earnings and revenue surprises of 0% and 10.01%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?